Jenevra Azzopardi, CPhT | PAAS National

About Jenevra Azzopardi, CPhT

I grew up in a family of nurses and other medical professionals but was never interested in the clinic setting. I was drawn to pharmacy because I like to help people and could easily use the knowledge I grew up with to do so. It was a great fit.  

I have a Bachelor of Arts in Communications from the University of Wisconsin – Madison. Prior to joining PAAS in 2017, I worked for Walgreens for 19 years.

As an Analyst at PAAS, I really enjoy being able to help independent pharmacies succeed. I have always been a fan of the underdog and am excited to be able to give you the tools you need to take on the giants of the PBM industry.

Entries by Jenevra Azzopardi, CPhT

Incorrect NDC or NPI Billed? Humana Requires Corrections

July 25, 2023

Humana has recently sent out another round of audits where either an incorrect NDC number or National Provider Identifier (NPI) was billed.

At Your Own Risk: “Use as Directed”

July 23, 2023

How many times have you received a prescription for a bowel prep, starter pack, or pre-packaged taper where the directions simply state, “Use as Directed?”

Off-Label Use Beyond GLP-1

June 29, 2023

GLP-1 medications being used off-label for weight loss, and the corresponding audit risk, has been a hot topic for awhile now, but there are other medications that PAAS National^® frequently sees recoupments for when being used off-label, especially when billed to a Medicare plan.

Insurance Limits Quantity – Common Scenarios and Pitfalls

June 23, 2023

When processing prescriptions, insurance companies require pharmacies to bill an accurate days’ supply derived from mathematical calculations obtained from the directions.

Quantity Changes Cause Audit Appeal Trouble

June 7, 2023

PAAS National^® is seeing more discrepancies for “unauthorized” refills on audits and PBMs continue to make these discrepancies difficult to appeal.

Best Practices: Medication Delivery

April 21, 2023

With the Public Health Emergency (PHE) for COVID-19 ending May 11, 2023, a return to pre-pandemic requirements for proving patient receipt of medications is anticipated.

Audit Trap: OptumRx’s Provider Manual Requirements

March 19, 2023

PAAS National^® is starting to see more recoupments from OptumRx for missing prescription information.

PHE for COVID-19 Ending May 11, 2023: Pharmacy and Audit Ramifications

March 17, 2023

On January 30, 2023, President Biden’s administration announced that both the national emergency and public health emergency (PHE) for COVID-19 would be ending on May 11, 2023. This will have far-reaching implications for everyone in healthcare, including pharmacy.

Audit Risk: Pre-Printed Prescription Forms

February 21, 2023

At a time when the workday seems to be growing ever more hectic, prescribers and pharmacies may find pre-printed prescription forms convenient; especially for medications which are frequently utilized by a prescriber for treatment. Many PBMs prohibit pre-printed prescription form use for various reasons.

Why Does Billing the Correct Origin Code Matter?

February 17, 2023

Pharmacies are required to enter an origin code on claims to indicate where the prescription came from or “originated.”